Oncoloxía Traslacional
![Foto de Oncoloxía Traslacional](/img/grupo.png)
![Foto de Hospital POVISA](/img/noimage_org.png)
Hospital POVISA
Vigo, EspañaPublicacións en colaboración con investigadores/as de Hospital POVISA (15)
2022
2021
-
Do clinical trials meet current care needs? Views of digestive oncology specialists in galicia (spain) using the delphi method
Healthcare (Switzerland), Vol. 9, Núm. 6
-
Efficacy and safety of Nivolumab in older patients with pretreated lung cancer: A subgroup analysis of the Galician lung cancer group
Journal of Geriatric Oncology, Vol. 12, Núm. 3, pp. 410-415
-
Rethinking prognostic factors in locally advanced or metastatic urothelial carcinoma in the immune checkpoint blockade era: a multicenter retrospective study
ESMO open, Vol. 6, Núm. 2, pp. 100090
2020
-
First-line panitumumab plus capecitabine for the treatment of older patients with wild-type RAS metastatic colorectal cancer. The phase II, PANEL study
Journal of Geriatric Oncology, Vol. 11, Núm. 8, pp. 1263-1267
-
PD-(L)1 inhibitors in combination with chemotherapy as first-line treatment for non-small-cell lung cancer: A pairwise meta-analysis
Journal of Clinical Medicine, Vol. 9, Núm. 7, pp. 1-13
2019
-
Chemotherapy management for unfit patients with metastatic castration-resistant prostate cancer
Clinical and Translational Oncology, Vol. 21, Núm. 3, pp. 249-258
-
Efficacy and safety of FOLFIRI/Aflibercept (FA) in an elderly population with metastatic colorectal cancer (mCRC) after the failure of an oxaliplatin-based regimen
Annals of Oncology, Vol. 30, pp. iv42-iv43
2018
-
Real world data of nivolumab for previously treated non-small cell lung cancer patients: A Galician lung cancer group clinical experience
Translational Lung Cancer Research, Vol. 7, Núm. 3, pp. 404-415
2016
-
EGFR testing and clinical management of advanced NSCLC: A galician lung cancer group study (GGCP 048-10)
Cancer Management and Research, Vol. 8, pp. 11-20
-
Fluorescence in situ hybridization analysis of the ALK gene in 2,045 non-small cell lung cancer patients from North-Western Spain (Galicia)
Oncology Letters, Vol. 12, Núm. 2, pp. 1403-1407
2014
-
A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): A Galician Lung Cancer Group (GGCP) study
Cancer Chemotherapy and Pharmacology, Vol. 73, Núm. 3, pp. 451-457
-
Second-line treatment in advanced non-small-cell lung cancer in the epidermal growth factor receptor wild-type population: Review of patient profile
Anti-Cancer Drugs, Vol. 25, Núm. 4, pp. 368-374
2012
-
First-line bevacizumab, cisplatin and vinorelbine plus maintenance bevacizumab in advanced non-squamous non-small cell lung cancer chemo-naïve patients
Expert Opinion on Pharmacotherapy, Vol. 13, Núm. 10, pp. 1389-1396
2007
-
Gemcitabine plus docetaxel as first-line chemotherapy in patients with advanced non-small cell lung cancer: A lung cancer Galician group phase II study
Cancer Chemotherapy and Pharmacology, Vol. 60, Núm. 5, pp. 725-732